4D Molecular Therapeutics Inc. is a clinical stage biopharmaceutical company focusing on advancements in medical technology. The company operates globally, working towards the delivery of transformative gene therapeutic products to treat severe genetic diseases and cancer.
Operating in the biotechnology sector, 4D Molecular Therapeutics Inc. uses its proprietary Therapeutic Vector Evolution platform to create customised gene delivery vehicles that target specific tissue types associated with underlying diseases. The company’s product pipeline targets three therapeutic areas: Ophthalmology, Pulmonology, and Cardiology.
Stay up to date on the share price of FDMT by adding it to your eToro watchlist.